Nextcure Inc (NXTC) 13F Filings: Institutional Buyers & Sellers (Q2 2026)

NXTC ranks #7463 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

NXTC is a disclosed holding of Jim Simons (Renaissance Technologies), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

30 institutions disclose a position in NXTC, but none treat it as a major bet — even Verdad Advisers, LP, its most concentrated holder, allocates just 0.1% of its own portfolio to it.

Affinity Asset Advisors, LLC has trimmed its NXTC position for two straight quarters, cutting it by $3.4M while still holding $67.1K.

NXTC is down 1.4% today, and institutions have been net sellers of $12.0M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

NXTC reported a net loss of $42.7M over the trailing twelve months.

• Not yet profitable — net loss of $42.7M over the trailing twelve months
• Revenue grew 252.6% year over year
• Net income improved year over year, from -$60.9M to -$42.7M
• Operating cash flow was negative, using $49.6M in cash
• Current ratio of 4.14x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.44x equity — within a conventional range